Data collection is paused while the tracker is being upgraded. The data below is complete up to 20 August 2026.

HBM Healthcare Investments

Switzerland · 45 portfolio companies · first tracked 28 May 2026

Portfolio

CompanySectorStageCountry
1000 Farmacie Healthtech
ADARx Biotech
ALX Oncology Biotech
Adrenomed AG Biotech
Alumis Biotech
Antiva Biosciences Femtech
Arrakis Therapeutics, USA Biotech
ArriVent Biopharma Biotech
C-Ray Therapeutics Biotech
Cathay Biotech Inc. Biotech
CellCentric Biotech
Connect RN HealthtechUnited States
Corxel Biotech
Crystalys Therapeutics Biotech
Cure Everlife Holdings Medtech
Curevo Vaccine carried forward from 30 May 2026 Biotech
Dren Bio Biotech
Electra Therapeutics Biotech
Fangzhou / Jianke Healthtech
Farmalatam Healthtech
Fore Biotherapeutics BiotechUnited States
Freenome carried forward from 24 July 2026 Biotech
Genalyte (USA) Healthtech
Harmony Biosciences Biotech
Ignis Therapeutics Biotech
Karius Biotech
Lycia Therapeutics Biotech
Mahzi Biotech
Mineralys Therapeutics BiotechUnited States
Monte Rosa Therapeutics Biotech
Neurelis Biotech
Neuron23, Inc. Biotech
NiKang Therapeutics Biotech
Nuance Biotech Biotech
Numab Therapeutics Biotech
Onesource
River Renal Biotech
Shape Memory Medical Medtech
Sphingotec Healthtech
Swixx Healthcare | Swixx Biopharma Biotech
TATA 1mg Healthtech
Upstream Bio Biotech
Valo Health Biotech
Visen Pharma Biotech
eGenesis BiotechUnited States

Recorded changes

Spotted something wrong? Tell us.